{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Ixazomib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ixazomib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ixazomib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "ixazomib",
    "trial_2_text": "Ixazomib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Ixazomib Supplement: 60 participants will take Ixazomib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ixazomib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ixazomib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.5572980642318726,
      "123": 0.3526970148086548,
      "9": 0.33472421765327454,
      "17": 0.3170629143714905,
      "20": 0.28945261240005493,
      "177": 0.27135637402534485,
      "78": 0.2697911858558655,
      "173": 0.26115524768829346,
      "37": 0.24748949706554413,
      "21": 0.2266930639743805,
      "188": 0.2258392721414566,
      "49": 0.2164808064699173,
      "189": 0.21528740227222443,
      "46": 0.2146652787923813,
      "68": 0.21383509039878845,
      "64": 0.21141211688518524,
      "67": 0.21060636639595032,
      "77": 0.2090453803539276,
      "14": 0.189606711268425,
      "228": 0.18509232997894287,
      "85": 0.17791849374771118,
      "200": 0.17519453167915344,
      "79": 0.17123596370220184,
      "2": 0.1674048751592636,
      "114": 0.16280366480350494,
      "239": 0.15955230593681335,
      "29": 0.1571352630853653,
      "180": 0.15343636274337769,
      "101": 0.14740289747714996,
      "243": 0.14392998814582825,
      "35": 0.14168576896190643,
      "72": 0.13982678949832916,
      "104": 0.13822828233242035,
      "350": 0.13797685503959656,
      "179": 0.13267715275287628,
      "116": 0.12925037741661072,
      "131": 0.1269240528345108,
      "76": 0.12645505368709564,
      "82": 0.12640008330345154,
      "126": 0.12115263193845749,
      "30": 0.12059589475393295,
      "27": 0.1158580556511879,
      "86": 0.1107327938079834,
      "204": 0.10906307399272919,
      "139": 0.10538274049758911,
      "288": 0.10417082160711288,
      "5": 0.10174939036369324,
      "61": 0.10015605390071869,
      "38": 0.09992039203643799,
      "36": 0.09689801186323166,
      "261": 0.09653612971305847,
      "69": 0.09592243283987045,
      "193": 0.0955105870962143,
      "249": 0.09502074122428894,
      "102": 0.094332255423069,
      "28": 0.0918741524219513,
      "92": 0.09031444787979126,
      "18": 0.0849541425704956,
      "396": 0.08450193703174591,
      "441": 0.08433828502893448,
      "186": 0.08362104743719101,
      "122": 0.08226292580366135,
      "147": 0.07907801121473312,
      "269": 0.07825392484664917,
      "194": 0.07713164389133453,
      "355": 0.07688423246145248,
      "130": 0.07553114742040634,
      "151": 0.07374902069568634,
      "253": 0.07305007427930832,
      "221": 0.07296020537614822,
      "361": 0.07046974450349808,
      "234": 0.07022886723279953,
      "142": 0.06781023740768433,
      "136": 0.06753966212272644,
      "286": 0.06751532852649689,
      "276": 0.0674501359462738,
      "98": 0.06740399450063705,
      "144": 0.06733416020870209,
      "466": 0.06688684970140457,
      "208": 0.0664895698428154,
      "4": 0.06611675769090652,
      "96": 0.06321840733289719,
      "75": 0.063011534512043,
      "535": 0.06295568495988846,
      "164": 0.062456049025058746,
      "1": 0.062281083315610886,
      "138": 0.061721205711364746,
      "256": 0.06162172555923462,
      "356": 0.061107195913791656,
      "195": 0.06095482036471367,
      "191": 0.060861699283123016,
      "282": 0.059519533067941666,
      "212": 0.059413377195596695,
      "456": 0.059355948120355606,
      "133": 0.058445077389478683,
      "163": 0.054663851857185364,
      "100": 0.05410800874233246,
      "154": 0.053447458893060684,
      "242": 0.053357597440481186,
      "489": 0.053242672234773636
    },
    "trial_2_ae": {
      "87": 0.5572980642318726,
      "123": 0.3526970148086548,
      "9": 0.33472421765327454,
      "17": 0.3170629143714905,
      "20": 0.28945261240005493,
      "177": 0.27135637402534485,
      "78": 0.2697911858558655,
      "173": 0.26115524768829346,
      "37": 0.24748949706554413,
      "21": 0.2266930639743805,
      "188": 0.2258392721414566,
      "49": 0.2164808064699173,
      "189": 0.21528740227222443,
      "46": 0.2146652787923813,
      "68": 0.21383509039878845,
      "64": 0.21141211688518524,
      "67": 0.21060636639595032,
      "77": 0.2090453803539276,
      "14": 0.189606711268425,
      "228": 0.18509232997894287,
      "85": 0.17791849374771118,
      "200": 0.17519453167915344,
      "79": 0.17123596370220184,
      "2": 0.1674048751592636,
      "114": 0.16280366480350494,
      "239": 0.15955230593681335,
      "29": 0.1571352630853653,
      "180": 0.15343636274337769,
      "101": 0.14740289747714996,
      "243": 0.14392998814582825,
      "35": 0.14168576896190643,
      "72": 0.13982678949832916,
      "104": 0.13822828233242035,
      "350": 0.13797685503959656,
      "179": 0.13267715275287628,
      "116": 0.12925037741661072,
      "131": 0.1269240528345108,
      "76": 0.12645505368709564,
      "82": 0.12640008330345154,
      "126": 0.12115263193845749,
      "30": 0.12059589475393295,
      "27": 0.1158580556511879,
      "86": 0.1107327938079834,
      "204": 0.10906307399272919,
      "139": 0.10538274049758911,
      "288": 0.10417082160711288,
      "5": 0.10174939036369324,
      "61": 0.10015605390071869,
      "38": 0.09992039203643799,
      "36": 0.09689801186323166,
      "261": 0.09653612971305847,
      "69": 0.09592243283987045,
      "193": 0.0955105870962143,
      "249": 0.09502074122428894,
      "102": 0.094332255423069,
      "28": 0.0918741524219513,
      "92": 0.09031444787979126,
      "18": 0.0849541425704956,
      "396": 0.08450193703174591,
      "441": 0.08433828502893448,
      "186": 0.08362104743719101,
      "122": 0.08226292580366135,
      "147": 0.07907801121473312,
      "269": 0.07825392484664917,
      "194": 0.07713164389133453,
      "355": 0.07688423246145248,
      "130": 0.07553114742040634,
      "151": 0.07374902069568634,
      "253": 0.07305007427930832,
      "221": 0.07296020537614822,
      "361": 0.07046974450349808,
      "234": 0.07022886723279953,
      "142": 0.06781023740768433,
      "136": 0.06753966212272644,
      "286": 0.06751532852649689,
      "276": 0.0674501359462738,
      "98": 0.06740399450063705,
      "144": 0.06733416020870209,
      "466": 0.06688684970140457,
      "208": 0.0664895698428154,
      "4": 0.06611675769090652,
      "96": 0.06321840733289719,
      "75": 0.063011534512043,
      "535": 0.06295568495988846,
      "164": 0.062456049025058746,
      "1": 0.062281083315610886,
      "138": 0.061721205711364746,
      "256": 0.06162172555923462,
      "356": 0.061107195913791656,
      "195": 0.06095482036471367,
      "191": 0.060861699283123016,
      "282": 0.059519533067941666,
      "212": 0.059413377195596695,
      "456": 0.059355948120355606,
      "133": 0.058445077389478683,
      "163": 0.054663851857185364,
      "100": 0.05410800874233246,
      "154": 0.053447458893060684,
      "242": 0.053357597440481186,
      "489": 0.053242672234773636
    }
  },
  "safety": {
    "trial_1_safety": 0.4969402551651001,
    "trial_2_safety": 0.4969402551651001
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47955289483070374
  }
}